Donate
Sign Up

Board of Directors

Mark Taxel

Chair and Founder
President, Hayrake Management, Inc.
Former Executive Vice President, Marketing Jos. E. Seagram and Sons

Harmony Knutson

President and CEO
Board Member, 314 Action

Samantha J. Silver

Vice President and Secretary
Chief of Strategy and Operations, Measures for Justice

David Lord

Treasurer
Executive Vice President and General Manager, Nexa

Deborah Bhatt

Founder, Vesta New York

Alexander Carey

Marketing and communications executive and senior political strategist

Benjamin Geyerhahn

Consultant, former CEO and Co-founder Workers Benefit Consortium

Fred Kirschner

Former Co-Owner, Kirschner Brothers Oil Company

Michael McCurdy, MD

Critical Care Physician, Researcher and Innovator

Michael Rolnick, MD

Founding CEO and former President, National Foundation of Emergency Medicine

Laurie Scheinman

Entrepreneur and Philanthropist
Director: UJA and Planned Parenthood

Nelson Taxel

CEO, Positive Promotions

Alex Wolin

Vice President of Sales - North America, Persefoni

Linda Taxel

Honorary Co-Chair

More healthy survivors, less family heartbreak.

Your generous donation has the power to save lives.

Together, we will END rare cancer.

Donate
rare cancer
About Rare Cancer News & Information
foundation
About the Foundation About Jed Why Support Us Board of Directors Medical Advisory Board Strategic Partnerships Our Years of Progress Report
impact
Alliance for Rare Cancers CURE Rare Cancer Initiative Rare Cancer Landscape Study Rare Cancer Research 2023 Rare Cancer Workshop 2022 Rare Cancer Conference Jedis for Survival
updates, events & more
Newsletter Blog Events Contact Us Privacy Policy Form 990

Subscribe to our e-News Updates

Learn about lifesaving rare cancer research, foundation news, events, and discoveries that make a real, measurable difference in the lives of rare cancer patients and their families.

Your Voice Matters

Comment, Like, Share & Follow Us on Social Media.

Together, we can take action against rare cancer and help save lives.

Platinum Transparency 2023 Candid

The Jed Ian Taxel Foundation for Rare Cancer Research | P.O. Box 683501 Park City, Utah 84068

The Jed Ian Taxel Foundation for Rare Cancer Research, Inc. is a 501 (C)(3) Non-Profit Organization, accepting Tax Deductible donations from individuals, corporations, family-advised funds and foundations. Federal Tax ID 86-2610819

DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

© 2025 All Rights Reserved.
website development new york

Subscribe to our e-News Updates

Learn about lifesaving rare cancer research, foundation news, events, and discoveries that make a real, measurable difference in the lives of rare cancer patients and their families.